BridgeBio Pharma
BBIO
BBIO
200 hedge funds and large institutions have $8.46B invested in BridgeBio Pharma in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 80 increasing their positions, 60 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
200
Holders Change
+2
Holders Change %
+1.01%
% of All Funds
3.49%
Holding in Top 10
15
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.26%
New
30
Increased
80
Reduced
60
Closed
27
Calls
$19.2M
Puts
$28.7M
Net Calls
-$9.52M
Net Calls Change
-$5.64M
Top Buyers
Top Sellers
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
$20.5M |
| 2 |
SUT
SC US (TTGP)
Menlo Park,
California
|
$113M |
| 3 |
Two Sigma Investments
New York
|
$956K |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$50.1M |
| 5 |
BAMCO Inc
New York
|
$42.2M |
